sofosbuvir has been researched along with Waldenstrom Macroglobulinemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dholaria, B; Juskevicius, R; Moreno Vanegas, YA | 1 |
Ballestrero, A; Brunacci, M; Crespi, M; Demarzo, MG; Ferrando, F; Giannini, EG; Grillo, F; Pellegatta, G; Savarino, V | 1 |
1 review(s) available for sofosbuvir and Waldenstrom Macroglobulinemia
Article | Year |
---|---|
Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals.
Topics: Antiviral Agents; Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunohistochemistry; Liver Cirrhosis; Middle Aged; Severity of Illness Index; Simeprevir; Sofosbuvir; Treatment Outcome; Waldenstrom Macroglobulinemia | 2018 |
1 other study(ies) available for sofosbuvir and Waldenstrom Macroglobulinemia
Article | Year |
---|---|
Hepatitis C Virus-associated Lymphoplasmacytic Lymphoma With Waldenström Macroglobulinemia: Response to Direct-acting Antiviral Therapy.
Topics: Benzimidazoles; Fluorenes; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sofosbuvir; Waldenstrom Macroglobulinemia | 2020 |